G215-1766 Screening compound: 4-(3-bromobenzyl)-N~3~-cyclopentyl-3-methyl-5-oxo-2,3,4,5-tetrahydro[1]benzofuro[2,3-f][1,4]oxazepine-3-carboxamide

G215-1766 Screening compound: 4-(3-bromobenzyl)-N~3~-cyclopentyl-3-methyl-5-oxo-2,3,4,5-tetrahydro[1]benzofuro[2,3-f][1,4]oxazepine-3-carboxamide
G215-1766 Screening compound: 4-(3-bromobenzyl)-N~3~-cyclopentyl-3-methyl-5-oxo-2,3,4,5-tetrahydro[1]benzofuro[2,3-f][1,4]oxazepine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G215-1766
4-(3-bromobenzyl)-N~3~-cyclopentyl-3-methyl-5-oxo-2,3,4,5-tetrahydro[1]benzofuro[2,3-f][1,4]oxazepine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G215-1766

Molecular Formula

C25H25BrN2O4 (C25 H25 BrN2 O4)

Compound Name

4-(3-bromobenzyl)-N~3~-cyclopentyl-3-methyl-5-oxo-2,3,4,5-tetrahydro[1]benzofuro[2,3-f][1,4]oxazepine-3-carboxamide

IUPAC name

11-[(3-bromophenyl)methyl]-N-cyclopentyl-12-methyl-10-oxo-814-dioxa-11-azatricyclo[7.5.0.0^{27}]tetradeca-1(9)2(7)35-tetraene-12-carboxamide

SMILES

CC(COc1c2oc3c1cccc3)(C(NC1CCCC1)=O)N(Cc1cccc(Br)c1)C2=O

InChI

InChI=1S/C25H25BrN2O4/c1-25(24(30)27-18-9-2-3-10-18)15-31-21-19-11-4-5-12-20(19)32-22(21)23(29)28(25)14-16-7-6-8-17(26)13-16/h4-8,11-13,18H,2-3,9-10,14-15H2,1H3,(H,27,30)/t25-/m0/s1

InChI Key

AUPQUXQUTSSIOS-VWLOTQADSA-N

MDL Number (MFCD)

MFCD27211002

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.39

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.684

Distribution Coefficient, logD

5.684

Water Solubility, LogSw

-5.64

Polar Surface Area

57.050

Acid Dissociation Constant (pKa)

15.33

Base Dissociation Constant (pKb)

1.61

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.00

G215-1766 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Cyclic Ugi PPI Library (9586 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Developmental Pathway (Hh/Wnt) Set (2238 compounds)

New Agro Library (44492 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Others
Agro:
  • Agro

References: we are preparing a list of scientific research reports with G215-1766 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G215-1766?
Check Price and Availability of G215-1766, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G215-1766 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G215-1766
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G215-1766
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G215-1766 available by request